76
Views
0
CrossRef citations to date
0
Altmetric
Article

Detailed epidemiological analysis as a strategy for evaluating the actual behavior of tuberculosis in an apparently low-incidence region

, ORCID Icon, , ORCID Icon, & ORCID Icon

References

  • Bonita R, Beaglehole R, Kjellstrèom T. Basic Epidemiology. 2nd ed. Geneva: World Health Organization; 2006.
  • Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91–99.
  • Lau C, Smythe L, Weinstein P. Leptospirosis: an emerging disease in travellers. Travel Med Infect Dis. 2010;8:33–39.
  • Bousquet A, Malfuson JV, Sanmartin N, et al. 8‐year survey of strains identified in blood cultures in a clinical haematology unit. Clin Microbiol Infect. 2014;20(1):O7–O12.
  • Peña C, Suarez C, Tubau F, et al. Nosocomial spread of Pseudomonas aeruginosa producing the metallo‐β‐lactamase VIM‐2 in a Spanish hospital: clinical and epidemiological implications. Clin Microbiol Infect. 2007;13(10):1026–1029.
  • Aviles LA. Epidemiology as discourse: the politics of development institutions in the epidemiological profile of El Salvador. J Epidemiol Community Health. 2001;55(3):164–171.
  • Gupte MD, Ramachandran V, Mutatkar RK. Epidemiological profile of India: historical and contemporary perspectives. J Biosci. 2001;26(4):437–464.
  • Reef SE, Redd SB, Abernathy E, et al. The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998–2004: the evidence for absence of endemic transmission. Clin Infect Dis. 2006;43(Suppl 3):S126–S132.
  • Tumbarello M, Sali M, Trecarichi EM, et al. Bloodstream infections caused by extended-spectrum-β-lactamase-producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother. 2008;52(9):3244–3252.
  • CDC. Integrated guidance for developing epidemiologic profiles: HIV prevention and Ryan White HIV/AIDS programs planning. Atlanta, Georgia: Centers for Disease Control and Prevention; 2014 [cited 2015 Apr 22]. Available from: http://www.cdc.gov/hiv/pdf/guidelines_developing_epidemiologic_profiles.pdf
  • Foxman B, Riley R. Molecular epidemiology: focus on infection. Am J Epidemiol. 2001;153(12):1135–1141.
  • Kola A, Holst M, Chaberny IF, et al. Surveillance of extended-spectrum β-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect. 2007;66(1):46–51.
  • Wroblewska MM, Towner KJ, Marchel H, et al. Emergence and spread of carbapenem‐resistant strains of Acinetobacter baumannii in a tertiary‐care hospital in Poland. Clin Microbiol Infect. 2007;13(5):490–496.
  • Howell F, Kelly P, Clancy L. Pulmonary tuberculosis in the Republic of Ireland: an epidemiological profile from a single unit. Respir Med. 1990;84(2):111–117.
  • Aerts D, Jobim R. The epidemiological profile of tuberculosis in southern Brazil in times of AIDS. Int J Tuberc Lung Dis. 2004;8(6):785–791.
  • Coker R, Bell A, Pitman R, et al. Tuberculosis screening in migrants in selected European countries shows wide disparities. Eur Resp J. 2006;27(4):801–807.
  • Oliveira HMDMG, Brito RC, Kritski AL, et al. Epidemiological profile of hospitalized patients with TB at a referral hospital in the city of Rio de Janeiro, Brazil. J Bras Pneumol. 2009;35(8):780–787.
  • Silva DR, Menegotto DM, Schulz LF, et al. Factors associated with mortality in hospitalized patients with newly diagnosed tuberculosis. Lung. 2010;188(1):33–41.
  • Sreeramareddy CT, Ramakrishnareddy N, Shah RK, et al. Clinico-epidemiological profile and diagnostic procedures of pediatric tuberculosis in a tertiary care hospital of western Nepal-a case-series analysis. BMC Pediatr. 2010;10:57.
  • Montoro E, Rodriguez R. Global Burden of Tuberculosis. In: Palomino JC, Cardoso-Leão S, Ritacco V, editors. Tuberculosis 2007: from basic science to patient care. Belgium, Brazil, Argentina: TuberculosisTextbook.com; 2007. p. 263–282.
  • Dye C, Borgdorff M. Global epidemiology and control of tuberculosis. In: Kaufmann SH, van Helden P, editors. Handbook of tuberculosis: clinics, diagnostics, therapy and epidemiology. Weinheim: WILEY-VCH Verlag GmbH & Co.; 2008. p. 1–21.
  • Nellson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis. 2004;8(5):636–647.
  • Musellim B, Erturan S, Sonmez-Duman E, et al. Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation. Int J Tuberc Lung Dis. 2005;9(11):1220–1223.
  • WHO. Global tuberculosis report. Geneva: World Health Organization; 2014. p. 154.
  • WHO. Tuberculosis country profiles. World Health Organization; 2014 [cited 2016 Mar 14]. Available from: http://www.who.int/tb/country/data/profiles/en/
  • Castellanos-Joya M Situación actual de la Tuberculosis en México. Avances y desafíos. Presentación en el XV Curso de Actualización en el Diagnóstico y Tratamiento de la Tuberculosis en el Niño y el Adulto; México, DF; 2012.
  • Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Eur Resp J. 2002;19(4):765–775.
  • WHO, ERS. Towards TB elimination in Low-incidence countries. World Health Organization. [cited 2014 Jun 25]. Available from: http://www.who.int/tb/publications/Towards_TB_Eliminationfactsheet.pdf
  • Bryce J, Victora CG, Habicht JP, et al. Programmatic pathways to child survival: results of a multi-country evaluation of integrated management of childhood illness. Health Policy Plan. 2005;20(Suppl1):i5–i17.
  • SINAVE. Sistema Nacional de Vigilancia Epidemiológica. 2013 [cited 2013 Oct 20]. Available from: http://www.sinave.gob.mx/
  • INEGI. México en Cifras: información Nacional, por Entidad Federativa y Municipios. 2012 [cited 2012 Nov 13]. Available from: http://www3.inegi.org.mx/sistemas/mexicocifras/default.aspx?e=16
  • PNUD. Informe para el Desarrollo Humano. Michoacán 2007. México DF: Programa de las Naciones Unidas para el Desarrollo; 2007. p. 151.
  • WHO. Global tuberculosis report 2013. Geneva: World Health Organization; 2013. p. 289.
  • QGIS. A free and open source geographic information system. [cited 2013 May 30]. Available from: http://www.qgis.org/en/site/
  • INEGI. Sistema para la Consulta de información Censal, v.05/2012. Instituto Nacional de Geografía Estadística e Informática; 2012 [cited 2014 Jul 28]. Available from: http://www.inegi.org.mx/est/scince/scince2010.aspx
  • WHO. Global tuberculosis report. Geneva: World Health Organization; 2018.
  • Kritski A, Fiuza de Melo A. Tuberculosis in Adults. In: Palomino JC, Cardoso-Leão S, Ritacco V, editors. Tuberculosis 2007: from basic science to patient care. Belgium, Brazil, Argentina: TuberculosisTextbook.com; 2007. p. 487–524.
  • Nguyen VA, Choisy M, Nguyen DH, et al. High prevalence of Beijing and EAI4-VNM genotypes among M. tuberculosis isolates in northern Vietnam: sampling effect, rural and urban disparities. PLoS One. 2012;7(9):e45553.
  • Kapata N, Chanda-Kapata P, Ngosa W, et al. The prevalence of tuberculosis in Zambia: results from the first national TB prevalence survey, 2013–2014. PLoS One. 2016;11(1):e0146392.
  • Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung D. 2004;8(4):392–402.
  • Snow KJ, Cruz AT, Seddon JA, et al. Adolescent tuberculosis. Lancet Child Adolesc Health. 2020;4(1):68–79.
  • WHO. Assessment of surveillance data – workbook. Geneva: World Health Organization; 2012 [cited 2015 Mar 21]. Available from: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/resources_documents/workbook.pdf
  • Oliveira GP, Pinheiro RS, Medina Coeli C, et al. Mortality information system for identifying underreported cases of tuberculosis in Brazil. Rev Bras Epidemiol. 2012;15(3):468–477.
  • Melosini L, Vetrano U, Dente FL, et al. Evaluation of underreporting tuberculosis in Central Italy by means of record linkage. BMC Public Health. 2012;12:472.
  • Purwati UD, Riyudha F, Tasman H. Optimal control of a discrete age-structured model for tuberculosis transmission. Heliyon. 2020;6(1):e03030.
  • Oliveira Sousa LM, Pinheiro RS. Unnotified deaths and hospital admissions for tuberculosis in the municipality of Rio de Janeiro. Rev Saude Publica. 2011;45(1):31–39.
  • Campogiani L, Compagno M, Coppola L, et al. Tuberculosis-related hospitalizations in a low-incidence country: a retrospective analysis in two Italian infectious diseases wards. Int J Environ Res Public Health. 2020;17(1):124.
  • Banta JE, Ani C, Bvute KM, et al. Pulmonary vs. extra-pulmonary tuberculosis hospitalizations in the US [1998–2014]. J Infect Public Health. 2020;13(1):131–139.
  • Fanlo P, Tiberio G. Extrapulmonary tuberculosis. An Sist Sanit Navar. 2007;30(Suppl 2):143–162.
  • SAGARPA. Plan Estratégico de la Campaña Nacional Contra la Tuberculosis Bovina 2008–2012. Secretaría de Agricultura, Ganadería, Desarrollo Rural, Pesca y Alimentación; 2012 [cited 2014 Jun 30]. Available from: http://www.senasica.gob.mx/?id=4370
  • Rosales-Castillo JA, Vázquez-Garcidueñas MS, Hernández-Álvarez H, et al. Genetic diversity and population structure of Escherichia coli from neighboring small-scale dairy farms. J Microbiol. 2011;49(5):693–702.
  • Hlavsa MC, Moonan PK, Cowan LS, et al. Human tuberculosis due to Mycobacterium bovis in the United States, 1995–2005. Clin Infect Dis. 2008;47(2):168–175.
  • Majoor CJ, Magis-Escurra C, van Ingen J, et al. Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993–2007. Emerg Infec Dis. 2011;17(3):457–463.
  • Kantor IN, Ambroggi M, Poggi S, et al. Human Mycobacterium bovis infection in ten Latin American countries. Tuberculosis. 2008;88(4):358–365.
  • Müller B, Dürr S, Alonso S, et al. Mycobacterium bovis-induced tuberculosis in humans. Emerg Infect Dis. 2013;19:899–908.
  • Pérez-Guerrero L, Millián-Suazo F, Arriaga-Díaz C, et al. Epidemiología molecular de las tuberculosis bovina y humana en una zona endémica de Querétaro, México. Salud Pub Mex. 2008;50(4):286–291. .
  • Portillo-Gómez P, Sosa-Iglesia EG. Molecular identification of Mycobacterium bovis and the importance of zoonotic tuberculosis in Mexican patients. Int J Tuberc Dis. 2011;15(10):1409–1414. .
  • Vázquez-Marrufo G, Marín-Hernandez D, Zavala Páramo MG, et al. Genetic diversity among Mycobacterium tuberculosis isolates from Mexican patients. Can J Microbiol. 2008;54:610–618.
  • Butkeviciute E, Jones CE, Smith SG. Heterologous effects of infant BCG vaccination: potential mechanisms of immunity. Future Microbiol. 2018;13(10):1193–1208.
  • WHO. Global health observatory data repository: BCG immunization coverage estimates by country. Geneva: World Health Organization; 2009. Available from: https://apps.who.int/gho/data/view.main.80500?lang=en
  • Laifer G, Widmer AF, Simcock M, et al. TB in a low-incidence country: differences between new immigrants, foreign-born residents and native residents. Am J Med. 2007;120(4):350–356.
  • Odone A, Riccò M, Morandi M, et al. Epidemiology of tuberculosis in a low-incidence Italian region with high immigration rates: differences between not Italy-born and Italy-born TB cases. BMC Public Health. 2011;11:376.
  • Peerek M, Watson JP, Ormerod LP, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis. 2011;11(6):435–444.
  • Kamper-Jørgensen Z, Bengaard-Andersen A, Kok-Jensen A, et al. Migrant tuberculosis: the extent of transmission in a low burden country. BMC Infect Dis. 2012;12:60.
  • Tessema B, Beer J, Merker M, et al. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia. BMC Infect Dis. 2013;13:131.
  • Reis-Santos B, Locatelli R, Horta BL, et al. Socio-Demographic and clinical differences in subjects with tuberculosis with and without diabetes mellitus in Brazil – a multivariate analysis. PLoS One. 2013;8(4):e62604.
  • Rosales S, Pineda-García L, Ghebremichael S, et al. Molecular diversity of Mycobacterium tuberculosis isolates from patients with tuberculosis in Honduras. BMC Microbiol. 2010;10:208.
  • Nava-Aguilera E, López-Vidal Y, Harris E, et al. Clustering of Mycobacterium tuberculosis cases in Acapulco: spoligotyping and risk factors. Clin Dev Immunol. 2011;2011:408375.
  • Molina-Torres CA, Moreno-Torres E, Ocampo-Candiani J, et al. Mycobacterium tuberculosis spoligotypes in Monterrey, Mexico. J Clin Microbiol. 2010;48(2):448–455.
  • López-Rocha E, Juárez-Álvarez J, Riego-Ruiz L, et al. Genetic diversity of the Mycobacterium tuberculosis complex in San Luis Potosí, México. BMC Res Notes. 2013;6:172.
  • Sánchez-Pérez HJ, Díaz-Vázquez A, Nájera-Ortíz JC, et al. Multidrug-resistant pulmonary tuberculosis in Los Altos, Selva and Norte regions, Chiapas, Mexico. Int J Tuberc Lung Dis. 2010;4(1):34–39.
  • Dye C, Lönnroth K, Jaramillo E, et al. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ. 2009;87(9):683–691.
  • Chaimowicz F. Age transition of tuberculosis incidence and mortality in Brazil. Rev Saude Publica. 2001;35(1):81–87.
  • Dye C, Bourdin Trunz B, Lönnroth K, et al. Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS ONE. 2011;6(6):e21161.
  • Palmero DJ. Tuberculosis and HIV/AIDS. In: Palomino JC, Cardoso-Leão S, Ritacco V, editors. Tuberculosis 2007: from basic science to patient care. Belgium, Brazil, Argentina: TuberculosisTextbook.com; 2007. p. 559–592.
  • Cowger TL, Wortham JM, Burton DC. Epidemiology of tuberculosis among children and adolescents in the USA, 2007–17: an analysis of national surveillance data. Lancet Public Health. 2019;4(10):e506–e516.
  • Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1 infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr. 2000;23(1):75–80.
  • Nandakumar KV, Duraisamy K, Balakrishnan S, et al. Outcome of tuberculosis treatment in patients with diabetes mellitus treated in the revised national tuberculosis control programme in Malappuram District, Kerala, India. PLoS One. 2013;8(10):e76275.
  • Ponce-De-Leon A, Garcia-Garcia ML, Garcia-Sancho C, et al. Tuberculosis and diabetes in Southern Mexico. Diabetes Care. 2004;27(7):1584–1590.
  • Jiménez-Corona M, Cruz-Hervert JP, García-García L, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013;68(3):214–220.
  • Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152.
  • Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737–746.
  • Mai TQ, Martinez E, Menon R, et al. Tuberculosis risk factors and Mycobacterium tuberculosis transmission among HIV-infected patients in Vietnam. Tuberculosis. 2019;115:67–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.